Does brachial artery flow-mediated dilation predict development of cardiac allograft vasculopathy in heart transplant recipients?

Does brachial artery flow-mediated dilation predict development of cardiac allograft vasculopathy in heart transplant recipients? - TCAV-FMD observational study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000032764

Enrollment

123

Registered

2018-07-01

Start date

2018-07-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart transplant recipients

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Heart transplant recipients who have a routine examination of post heart transplantation on admission among patient enrollment period

Exclusion criteria

Exclusion criteria: 1) Patients who don't have coronary angiography and intravascular ultrasounds examination because of various causes, for example renal dysfunction 2) Patients who don't have coronary angiography and intravascular ultrasounds data to compare between baseline and follow up 3) Deemed unsuitable by the primary investigator for other reasons

Design outcomes

Primary

Measure	Time frame
The relationship between the FMD value on baseline and the development of CAV from baseline to follow up	—

Secondary

Measure	Time frame
The relationship between the FMD value on baseline and the major adverse cardiac events from baseline to follow up	—

Countries

Japan

Contacts

Public ContactTakuya Watanabe

National cerebral and cardiovascular center in Japan Department of transplant medicine

watanabe.takuya@ncvc.go.jp0661701069

Outcome results